Femasys Inc. (FEMY)Healthcare | Medical Instruments & Supplies | Suwanee, United States | NasdaqCM
3.20 USD
+0.41
(14.695%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 3.30 +0.10 (3.094%) ⇧ (Aug. 28, 2026, 7:58 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 2:20 a.m. EDT
The immediate outlook is severely bearish as the stock has lost nearly 92% of its value over the last four years, with the most recent annual period showing another significant decline. While the price has stabilized slightly in the last two weeks after a sharp drop, the underlying business is deteriorating rapidly. Revenue is contracting at nearly 19% annually, and the company is generating substantial losses, evidenced by negative operating margins and a negative return on equity. The balance sheet is fragile, carrying debt significantly higher than its cash reserves, which creates a constant threat of liquidity issues or further dilution. Although analysts suggest a 'buy' rating based on potential warrant exercises and a reverse split, these are speculative events rather than signs of operational recovery. With no history of paying dividends and a business model currently shrinking and losing money, there is no compelling case for holding this security in the long term. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.665498 |
| AutoETS | 0.670307 |
| MSTL | 0.672220 |
| AutoTheta | 0.676269 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 35% |
| H-stat | 2.67 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.885 |
| Excess Kurtosis | 0.08 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 118.837 |
| Revenue per Share | 0.773 |
| Market Cap | 26,800,086 |
| Forward P/E | -1.51 |
| Beta | -2.09 |
| Website | https://femasys.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.65125 |
| Address1 | 3,950 Johns Creek Court |
| Address2 | Suite 100 |
| All Time High | 275.0 |
| All Time Low | 2.022 |
| Ask | 3.5 |
| Ask Size | 2 |
| Average Analyst Rating | 1.7 - Buy |
| Average Daily Volume10 Day | 3,958,290 |
| Average Daily Volume3 Month | 720,087 |
| Average Volume | 720,087 |
| Average Volume10Days | 3,958,290 |
| Beta | -2.092 |
| Bid | 2.4 |
| Bid Size | 2 |
| Book Value | 1.333 |
| City | Suwanee |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.2 |
| Current Ratio | 2.144 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 3.3499 |
| Day Low | 2.76 |
| Debt To Equity | 118.837 |
| Display Name | Femasys |
| Ebitda | -17,229,926 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.75 |
| Enterprise To Revenue | 13.11 |
| Enterprise Value | 30,146,830 |
| Eps Forward | -2.125 |
| Eps Trailing Twelve Months | -3.1 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 404 581 5903 |
| Fifty Day Average | 3.272 |
| Fifty Day Average Change | -0.07200003 |
| Fifty Day Average Change Percent | -0.022004897 |
| Fifty Two Week Change Percent | -65.125 |
| Fifty Two Week High | 22.2 |
| Fifty Two Week High Change | -19.0 |
| Fifty Two Week High Change Percent | -0.8558558 |
| Fifty Two Week Low | 2.022 |
| Fifty Two Week Low Change | 1.178 |
| Fifty Two Week Low Change Percent | 0.5825915 |
| Fifty Two Week Range | 2.022 - 22.2 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,624,023,000,000 |
| Float Shares | 7,348,751 |
| Forward Eps | -2.125 |
| Forward P E | -1.5058824 |
| Free Cashflow | -11,230,021 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 51 |
| Fullday Change | 0.41 |
| Fullday Change Percent | 14.6953 |
| Fullday Price | 3.299 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.60948 |
| Gross Profits | 1,401,492 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.03853 |
| Held Percent Institutions | 0.43523997 |
| Implied Shares Outstanding | 8,375,027 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Ipo Expected Date | 2,021-06-18 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,780,876,800 |
| Last Split Factor | 1:20 |
| Long Business Summary | Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia. |
| Long Name | Femasys Inc. |
| Market | us_market |
| Market Cap | 26,800,086 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_61212730 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -11,768,121 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 23,575,701 |
| Number Of Analyst Opinions | 3 |
| Open | 2.79 |
| Operating Cashflow | -17,651,812 |
| Operating Margins | -15.26661 |
| Payout Ratio | 0.0 |
| Phone | 770 500 3910 |
| Post Market Change | 0.09899998 |
| Post Market Change Percent | 3.0937493 |
| Post Market Price | 3.299 |
| Post Market Time | 1,787,961,499 |
| Previous Close | 2.79 |
| Price Hint | 4 |
| Price To Book | 2.4006002 |
| Price To Sales Trailing12 Months | 11.65476 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.41 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.66667 |
| Region | US |
| Regular Market Change | 0.41 |
| Regular Market Change Percent | 14.6953 |
| Regular Market Day High | 3.3499 |
| Regular Market Day Low | 2.76 |
| Regular Market Day Range | 2.76 - 3.3499 |
| Regular Market Open | 2.79 |
| Regular Market Previous Close | 2.79 |
| Regular Market Price | 3.2 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 526,013 |
| Return On Assets | -0.84225 |
| Return On Equity | -4.24966 |
| Revenue Growth | -0.189 |
| Revenue Per Share | 0.773 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 8,375,027 |
| Shares Percent Shares Out | 0.0519 |
| Shares Short | 434,999 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 194,148 |
| Short Name | Femasys Inc. |
| Short Percent Of Float | 0.052800003 |
| Short Ratio | 2.89 |
| Source Interval | 15 |
| State | GA |
| Symbol | FEMY |
| Target High Price | 23.0 |
| Target Low Price | 10.0 |
| Target Mean Price | 14.33333 |
| Target Median Price | 10.0 |
| Total Cash | 1,443,502 |
| Total Cash Per Share | 0.172 |
| Total Debt | 4,790,245 |
| Total Revenue | 2,299,497 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3.1 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 9.20125 |
| Two Hundred Day Average Change | -6.0012503 |
| Two Hundred Day Average Change Percent | -0.6522212 |
| Type Disp | Equity |
| Volume | 526,013 |
| Website | https://femasys.com |
| Zip | 30,024 |